Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
 |
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacksxconomy.com » Xconomy Venture Capital Feed - Nov 18, 2008 Biotech, Merck, University of Washington Luke Timmerman wrote: Not many people in the world have played a leading role in delivering 23 new drugs and vaccines to the U.S. market. Bennett Shapiro is the only person … Also tagged: aids, obesity, seattle, biotech, vc, mit, pain, biochemistry, university of washington, amgen, gardasil, merck, alzheimer s, icos, magnolia, national institutes of health, puget sound, accelerator, life sciences, rheumatoid arthritis, fred hutchinson cancer research center, enbrel, ikaria, puretech ventures, mark roth, celera, san juan islands, national blog main, seattle blog main, arch venture partners, carl weissman, elixir pharmaceuticals, bob nelsen, fate therapeutics, immunex, bennett shapiro, drugs for neglected diseases initiative, olympic mountains, mind and 38 life institute, vascular biogenics |
|
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacksxconomy.com » Xconomy Seattle - Nov 17, 2008 Biotech, Merck, University of Washington Luke Timmerman wrote: Not many people in the world have played a leading role in delivering 23 new drugs and vaccines to the U.S. market. Bennett Shapiro is the only person … Also tagged: aids, obesity, seattle, biotech, vc, mit, pain, biochemistry, university of washington, amgen, gardasil, merck, alzheimer s, icos, magnolia, national institutes of health, puget sound, accelerator, life sciences, rheumatoid arthritis, fred hutchinson cancer research center, enbrel, ikaria, puretech ventures, mark roth, celera, san juan islands, national blog main, seattle blog main, arch venture partners, carl weissman, elixir pharmaceuticals, bob nelsen, fate therapeutics, immunex, bennett shapiro, drugs for neglected diseases initiative, olympic mountains, mind and 38 life institute, vascular biogenics |
 |
Illumina Shows its Stuff to Wall Street, Stock Still Slidesxconomy.com » Xconomy - Nov 8, 2008 Biotech, Genetics, Instruments Luke Timmerman wrote: San Diego’s Illumina has a pretty amazing story to tell about exponential growth. The maker of genetic analysis tools has beaten or matched Wall Street earnings … Also tagged: google, biotech, genetics, applied biosystems, multiple sclerosis, fda, san diego, amgen, merck, type 1 diabetes, harvard, instruments, sergey brin, roche, etanercept, anne wojcicki, inflammatory bowel disease, life sciences, humira, illumina, 23andme, rheumatoid arthritis, abbott laboratories, enbrel, national blog main, george church, helicos biosciences, cowen and 38 co, san diego blog main, jay flatley, adalimumab, christian henry, tristan orpan, doug schenkel, peter gregersen |
|
Illumina Shows its Stuff to Wall Street, Stock Still Slidesxconomy.com » Xconomy Life Sciences Feed - Nov 7, 2008 Biotech, Genetics, Instruments Luke Timmerman wrote: San Diego’s Illumina has a pretty amazing story to tell about exponential growth. The maker of genetic analysis tools has beaten or matched Wall Street earnings … Also tagged: google, biotech, genetics, applied biosystems, multiple sclerosis, fda, san diego, amgen, merck, type 1 diabetes, harvard, instruments, sergey brin, roche, etanercept, anne wojcicki, inflammatory bowel disease, life sciences, humira, illumina, 23andme, rheumatoid arthritis, abbott laboratories, enbrel, national blog main, george church, helicos biosciences, cowen and 38 co, san diego blog main, jay flatley, adalimumab, christian henry, tristan orpan, doug schenkel, peter gregersen |
washingtonpost.com » washingtonpost.com - Courts, Judiciary - Nov 3, 2008
Diana Levine went to a medical clinic with a severe migraine headache. She wound up with gangrene and an amputated forearm, the victim of a rare side effect from a popular anti-nausea drug.
Also tagged: case, antonin scalia, food and drug administration, high, vermont, court, samuel alito, for, looms, large, henry waxman, anthony kennedy, drugmakers, demerol, diana levine, phenergan
injuryboard.com » InjuryBoard National News Desk - Oct 17, 2008
LEARN MORE Injuryboard on celebrex Injuryboard on bextra Injuryboard on Pfizer litigation FDA on celebrex Pfizer press release IMAGE SOURCE: Pfizer Web site banner Pfizer, the world's largest drug company …
Also tagged: heart attack, pfizer, merck, stroke, celebrex, fda and prescription drugs, major medical, bextra, cos 2 inhibitors
bloggingstocks.com » BloggingStocks - Oct 15, 2008
Filed under: Bad news, Law, Merck and Co (MRK) Merck (NYSE: MRK) lost a lot of legal cases over whether its arthritis drug caused heart problems in patients. It even spent $4.85 billion to settle a lot of the claims …
Also tagged: drugs, mrk, scientific research, scientificresearch, intthenews
bloggingstocks.com » BloggingStocks - Oct 14, 2008
Filed under: Bad news, Law, Merck and Co (MRK) Merck (NYSE:MRK) lost a lot of legal cases over whether its arthritis drug caused heart problems in patients. It even spent $4.85 billion to settle a lot of the claims …
Also tagged: drugs, mrk, scientific research, scientificresearch, intthenews
injuryboard.com » InjuryBoard National News Desk - Oct 14, 2008
LEARN MORE The Lancet – 10/14/08 Issue InjuryBoard on Vioxx NEMJ: APPROVe Study 3/17/05 Issue Merck Newsroom on Vioxx Vioxx Settlement U.S. National Library of Medicine on Pain Relievers Florida Joins Eight …
Also tagged: heart attack, arthritis, aleve, merck, fda and prescription drugs, major medical, dangerous and defective drugs, approve study
